ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,612,446 | +53.8% | 209,576 | +75.7% | 0.02% | +56.2% |
| Q2 2023 | $3,648,003 | +15.3% | 119,294 | +36.9% | 0.02% | +6.7% |
| Q1 2023 | $3,162,928 | +16.8% | 87,133 | +27.2% | 0.02% | +7.1% |
| Q4 2022 | $2,708,068 | +13.2% | 68,524 | +15.0% | 0.01% | 0.0% |
| Q3 2022 | $2,393,000 | +15.6% | 59,561 | +21.0% | 0.01% | +16.7% |
| Q2 2022 | $2,070,000 | +7.8% | 49,242 | -0.1% | 0.01% | +33.3% |
| Q1 2022 | $1,920,000 | +35.8% | 49,278 | +38.8% | 0.01% | +28.6% |
| Q4 2021 | $1,414,000 | +31.7% | 35,491 | +21.3% | 0.01% | +16.7% |
| Q3 2021 | $1,074,000 | -11.2% | 29,270 | -0.5% | 0.01% | -14.3% |
| Q2 2021 | $1,210,000 | -5.7% | 29,413 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $1,283,000 | +5.6% | 29,413 | +21.2% | 0.01% | +14.3% |
| Q4 2020 | $1,215,000 | – | 24,271 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |